Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Bhumika Karamshi
Observed name:
Bhumika V. Karamshi
Institution:
GlaxoSmithKline (United Kingdom)
Observed institutions:
GlaxoSmithKline (United Kingdom),
GlaxoSmithKline (United States),
GlaxoSmithKline (Germany),
GlaxoSmithKline Research & Development Limited (United Kingdom)
OpenAlex ID:
A5069477129
Structure-Based Optimization of Naphthyridones into Potent ATAD2 Bromodomain Inhibitors
2015
·
Paul Bamborough
, Chun-wa Chung
, et al.
·
Journal of Medicinal Chemistry
·
90
Fragment-Based Discovery of Low-Micromolar ATAD2 Bromodomain Inhibitors
2015
·
Emmanuel H. Demont
, Chun-wa Chung
, et al.
·
Journal of Medicinal Chemistry
·
86
Structure-Based Design of a Bromodomain and Extraterminal Domain (BET) Inhibitor Selective for the N-Terminal Bromodomains That Retains an Anti-inflammatory and Antiproliferative Phenotype
2020
·
Christopher R. Wellaway
, Paul Bamborough
, et al.
·
Journal of Medicinal Chemistry
·
59
A Qualified Success: Discovery of a New Series of ATAD2 Bromodomain Inhibitors with a Novel Binding Mode Using High-Throughput Screening and Hit Qualification
2019
·
Paul Bamborough
, Chun-wa Chung
, et al.
·
Journal of Medicinal Chemistry
·
31
Configuration of a High-Content Imaging Platform for Hit Identification and Pharmacological Assessment of JMJD3 Demethylase Enzyme Inhibitors
2012
·
Alpa Mulji
, Carl Haslam
, et al.
·
SLAS DISCOVERY
·
20
Novel 3-Oxazolidinedione-6-aryl-pyridinones as Potent, Selective, and Orally Active EP3 Receptor Antagonists
2010
·
Jian Jin
, Ángel Morales-Ramos
, et al.
·
ACS Medicinal Chemistry Letters
·
17
Reducing False Positives through the Application of Fluorescence Lifetime Technology: A Comparative Study Using TYK2 Kinase as a Model System
2021
·
Luke A. Greenhough
, Gabriella Clarke
, et al.
·
SLAS DISCOVERY
·
2
PDF
Show more works
View as search
Works count:
9
Citation count:
305
H-index:
6
I10-index:
6
Year
Topic
Type